Phase I in epidemiology, often referred to as the initial phase of a clinical trial, primarily aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a new intervention or treatment. This phase is crucial as it lays the groundwork for subsequent phases and involves rigorous testing in a controlled environment.
